Zimmer Biomet Holdings
ZBH
88.49
-1.19
-1.33%
Zimmer Biomet Holdings
US · ZBH
#1040 by market cap
Listed 1970
88.49
-1.19
-1.33%
Live - 5344 symbols - heartbeat 227s ago
· 2026-10-07 20:02
After-hours
88.00
-0.55%
- Market cap
- 16.88B
- P/E (TTM)i
- 21.48
- P/Bi
- 1.34
- EPSi
- 3.55
- Div yieldi
- 1.08%
- 52W posi
- 36%
Reader sentiment
Are you bullish or bearish on ZBH?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 17 analysts
Buy
Avg price target
106.93 +20.8%
Price target rangecurrent 88.49
Low95.00
Avg106.93
High120.00
Buy 35%
Hold 65%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-25 | BofA Securities | -- | HOLD | 110.00 |
| 2026-09-24 | BofA Securities | -- | HOLD | 110.00 |
| 2026-09-16 | Truist Financial | -- | HOLD | 106.00 |
| 2026-09-09 | Truist Financial | -- | HOLD | -- |
| 2026-09-08 | BofA Securities | -- | HOLD | 110.00 |
| 2026-08-17 | J.P. Morgan | -- | HOLD | 117.00 |
| 2026-08-13 | Citi | -- | HOLD | 99.00 |
| 2026-08-11 | BofA Securities | -- | HOLD | 110.00 |
| 2026-08-11 | Truist Financial | -- | HOLD | 106.00 |
| 2026-08-10 | CCORF | -- | BUY | 100.00 |
| 2026-08-07 | Truist Financial | -- | HOLD | 106.00 |
| 2026-08-06 | Wells Fargo | -- | HOLD | 103.00 |
| 2026-08-06 | William Blair | -- | HOLD | -- |
| 2026-08-06 | UBS | -- | BUY | 120.00 |
| 2026-08-06 | Truist Financial | -- | HOLD | 106.00 |
| 2026-08-06 | Baird | -- | HOLD | 104.00 |
| 2026-08-06 | Deutsche Bank | -- | HOLD | 98.00 |
| 2026-08-06 | Stifel | -- | BUY | 110.00 |
| 2026-08-06 | Citi | -- | HOLD | 99.00 |
| 2026-08-05 | TD Cowen | -- | BUY | 115.00 |
| 2026-08-05 | Needham | -- | HOLD | -- |
| 2026-08-05 | RBC Capital | -- | BUY | 110.00 |
| 2026-07-28 | UBS | -- | BUY | 115.00 |
| 2026-07-23 | BTIG | -- | HOLD | -- |
| 2026-07-10 | BTIG | -- | HOLD | -- |
Quant vs Street three independent views, side by side
StockVane factor grade
B
Momentum strategy signal
Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
3 2
■ Upgrades■ Downgrades
- 3 upgrades vs 2 downgrades among tracked analyst rating changes.
- Most recent: CCORF moved from Hold to Buy on 2026-08-10.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-08-10 | CCORF | HOLD → BUY | 100.00 |
| 2026-07-28 | UBS | SELL → BUY | 115.00 |
| 2026-03-23 | BTIG | BUY → HOLD | -- |
| 2026-01-05 | Evercore | HOLD → BUY | 120.00 |
| 2025-12-16 | Baird | BUY → HOLD | 100.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-05 | -- | ±6.29% | +2.45% (in line) |
| 2026/Q1 | 2026-04-28 | -- | ±5.45% | -10.57% (beat) |
| 2025/Q4 | 2026-02-10 | -- | ±6.83% | +1.86% (in line) |
| 2025/Q3 | 2025-11-05 | -- | ±6.27% | -15.15% (beat) |
| 2025/Q2 | 2025-08-07 | -- | ±10.85% | +7.99% (in line) |
| 2025/Q1 | 2025-05-05 | -- | ±7.28% | -11.62% (beat) |
| 2024/Q4 | 2025-02-06 | -- | ±5.82% | -5.14% (in line) |
| 2024/Q3 | 2024-10-30 | -- | ±8.12% | +5.71% (in line) |
| 2024/Q2 | 2024-08-07 | -- | ±7.04% | -3.43% (in line) |
| 2024/Q1 | 2024-05-02 | -- | ±7.14% | -0.92% (in line) |
| 2023/Q4 | 2024-02-08 | -- | ±5.81% | -3.54% (in line) |
| 2023/Q3 | 2023-11-07 | -- | ±6.88% | -3.08% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-07 20:02:42 · For reference only, not investment advice and not tailored to your situation.